REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/06/2026
Back to search
Official data from USPTO
APTIVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
APTIVA
ST13
US500000088071814Class
1, 5, 9, 10
Filing
88071814
Registration
6316056
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
60
Latest update
04/07/2026
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
08/09/2018
Registration date
04/06/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/06/2021
Last transaction
04/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
01/18/2021
First use in commerce
01/18/2021
Drawing code
4
Owner type
03
Owner location
San Diego, CA, US
Examiner
NOVAKOVIC, MIROSLAV
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Inova Diagnostics, Inc.
Representatives
Deborah J Peckham Barclay Damon LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products for scientific purposesbiomarkers for scientific testing; reagents for scientific and research use; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for medical research use and not for use in connection with detecting nucleic acid
Class 5
Pharmaceutical and veterinary productsfluorescence multi-analyte immunoassay system for medical diagnostic usegastrointestinalneurologicalautoimmuneinfectioushepatologicalrheumatologicnephrologicaldermatologicalcoagulationendocrinepulmonologicimmune system relatedrespiratory diseases; clinical diagnostic assays for medical purposesidentifying and diagnosing of gastrointestinalneurologicalautoimmuneinfectioushepatologicalrheumatologicnephrologicaldermatologicalcoagulationendocrinepulmonologicimmune system relatedrespiratory diseases; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for medical diagnostic use and not for use in connection with detecting nucleic acid
Class 9
Laboratory apparatus for testing of plasmaserumsputumfecalurine samples for research purposes; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for laboratory research use and not for use in connection with detecting nucleic acid
Class 10
Apparatus and instruments for medical diagnosismedical apparatus for diagnosingmonitoringtreating gastrointestinalneurologicalautoimmuneinfectioushepatologicalrheumatologicnephrologicaldermatologicalcoagulationendocrinepulmonologicimmune system relatedrespiratory diseases; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for medical diagnostic use and not for use in connection with detecting nucleic acid
Publications
History of USPTO decisions and trademark events.
60 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/27/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/27/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/27/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/27/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/27/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/06/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/27/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/26/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/13/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/12/2021
EX1G
SOU EXTENSION 1 GRANTED
02/12/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/12/2021
IUAF
USE AMENDMENT FILED
01/29/2021
EXT1
SOU EXTENSION 1 FILED
01/29/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/29/2021
EISU
TEAS STATEMENT OF USE RECEIVED
01/29/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/09/2020
PUBO
PUBLISHED FOR OPPOSITION
06/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/20/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
05/04/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/01/2020
EXPT
EXPARTE APPEAL TERMINATED
04/29/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/29/2020
ALIE
ASSIGNED TO LIE
04/28/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/24/2020
EXPI
EX PARTE APPEAL-INSTITUTED
04/24/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/24/2020
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
04/24/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/14/2020
GNFR
FINAL REFUSAL E-MAILED
04/14/2020
CNFR
FINAL REFUSAL WRITTEN
04/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/11/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/25/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/25/2020
CNSI
SUSPENSION INQUIRY WRITTEN
01/25/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/02/2019
GNSL
LETTER OF SUSPENSION E-MAILED
07/02/2019
CNSL
SUSPENSION LETTER WRITTEN
07/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2019
ALIE
ASSIGNED TO LIE
06/11/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/06/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/05/2019
GNSL
LETTER OF SUSPENSION E-MAILED
06/05/2019
CNSL
SUSPENSION LETTER WRITTEN
06/05/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/16/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/16/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/06/2018
GNRT
NON-FINAL ACTION E-MAILED
12/06/2018
CNRT
NON-FINAL ACTION WRITTEN
12/06/2018
DOCK
ASSIGNED TO EXAMINER
11/28/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/16/2018
NWAP
NEW APPLICATION ENTERED
08/13/2018
Continuous trademark protection
Get notified about every new filing that threatens APTIVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.